Statistics
Publications
204
Citations
32.7K
H-Index
68
Active since
1998
Mario Mandalà is an author at Ospedale Papa Giovanni XXIII specializing in oncology, medicine, and metastatic melanoma treatment.
Publications per year
1998–2025
204
204
Combined Vemurafenib and Cobimetinib in <i>BRAF</i> -Mutated Melanoma
James Larkin, Paolo A. Ascierto, Brigitte Dréno et al. · New England Journal of Medicine · 2014 · 2K citations · Full text
Medicine, Oncology, Pharmacology +16
Combined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma
Georgina V. Long, Daniil Stroyakovskiy, Helen Gogas et al. · New England Journal of Medicine · 2014 · 1.9K citations · Full text
Medicine, Oncology, Pharmacotherapy +14
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
Alexander M.M. Eggermont, Christian U. Blank, Mario Mandalà et al. · New England Journal of Medicine · 2018 · 1.9K citations · Full text
Pharmacy, Oncology, Pharmacotherapy +17
Adjuvant Dabrafenib plus Trametinib in Stage III<i>BRAF</i>-Mutated Melanoma
Georgina V. Long, Axel Hauschild, Mario Santinami et al. · New England Journal of Medicine · 2017 · 1.5K citations · Full text
Pharmacy, Oncology, Pharmacotherapy +17
1–5 of 204